جست‌وجوی استاد و پژوهشگر

• Nanostructured Materials
• Polymer Chemistry
• Drug Delivery Systems
• +۴ مورد دیگر

Szczepan Zapotoczny is a Professor at the Faculty of Chemistry, Jagiellonian University, Kraków, Poland. He leads the Nanoengineering of Functional Polymeric Materials research team and serves as head of the Nanotechnology of Polymers and Biomaterials group. His work focuses on nanostructured polymeric materials for biomedical and photochemical applications, including polymer brushes, nanocapsules for drug delivery, and hybrid nanomaterials. Education: PhD in Chemistry (1999, Jagiellonian University), Postdoc at University of Twente (Netherlands, 1999–2001). Research Highlights: Over 190 peer-reviewed publications (H-index 40), 10 patents, and commercialized technologies like drug-delivery nanocapsules and magnetic nanoparticles. Teaching: Courses in Physical Chemistry, Macromolecular Science, and Microscopic Methods. Research interests span polymer brushes , nanocapsules , magnetic/plasmonic hybrids , and advanced microscopy . Awards include the Prime Minister’s Medal for Inventiveness (2022) and multiple Rector’s Awards. Grants & Collaborations: Active in EU-funded projects, industry partnerships, and interdisciplinary collaborations. Labs/Teams: Directs state-of-the-art labs for nanomaterial synthesis and biomedical applications.

M.B. Villamilمشاهده پروفایل

دانشیار

• Soil Health
• Metagenomics
• Sustainable Cropping Systems
• +۷ مورد دیگر

M.B. Villamil is an Associate Professor in the Department of Crop Sciences at the University of Illinois at Urbana-Champaign. She also holds professorial appointments at the Center for Latin American and Caribbean Studies. Her work addresses sustainable food production through soil health optimization, linking agronomic practices to carbon/nutrient cycling, crop productivity, and greenhouse gas mitigation. Ph.D. in Crop Sciences (UIUC, 2005) M.S. in Agricultural Education (UIUC, 2007) M.S. in Agronomy (Universidad Nacional del Sur, Argentina, 2000) B.S. in Agronomy (Universidad Nacional del Sur, Argentina, 1995) Her research spans soil health, metagenomics, sustainable cropping systems, and biometry. Recent publications focus on rhizosphere dynamics, cover crop impacts on microbial communities, and nutrient management strategies. She employs interdisciplinary approaches integrating bioinformatics, agroecology, and statistical modeling. Dr. Villamil’s affiliations include the Center for Latin American and Caribbean Studies, reflecting her transnational academic engagement. Her work contributes to climate-smart agriculture and sustainable land management practices.

Daniel Murphyمشاهده پروفایل

استاد

• Lung Cancer
• Mesothelioma
• Cancer Research
• +۵ مورد دیگر

Professor Daniel Murphy is a Professor of Lung Cancer & Mesothelioma at the University of Glasgow's Institute of Cancer Sciences, based at the CRUK Beatson Institute. His research focuses on understanding the molecular mechanisms underlying lung cancer and mesothelioma, with particular emphasis on genetically engineered mouse models and kinase signaling pathways. His work bridges basic science with clinical applications to develop new therapeutic approaches. Professor Murphy's research interests span multiple areas of cancer biology, with a strong focus on lung cancer and mesothelioma pathogenesis. His laboratory investigates how oncogenes like MYC drive tumor development and progression, with particular attention to metabolic reprogramming, kinase signaling networks, and the role of environmental factors like asbestos in mesothelioma. He has made significant contributions to understanding NUAK1 kinase signaling in cancer, centrosome regulation in pancreatic cancer, and mitochondrial dysfunction in tumor progression. His work often employs sophisticated genetically engineered mouse models to study cancer biology in physiologically relevant contexts. Analysis of Professor Murphy's recent publications reveals a strong thematic focus on molecular mechanisms of cancer development, with particular emphasis on kinase signaling pathways (especially NUAK1), metabolic reprogramming in tumors, and the molecular basis of mesothelioma. His research increasingly incorporates advanced computational approaches, as evidenced by publications on histomorphological atlases using self-supervised learning. The work spans basic molecular mechanisms to translational applications, with several studies identifying potential therapeutic targets in liver cancer, pancreatic cancer, and myeloproliferative disorders. Pharmacological inhibition of MYC in lung cancer (Beatson Cancer Charity, 2025-2026) Dactinomycin has an immunopotentiation effect by inducing MHC-I expression of cancer cells (University of Oxford, 2024-2025) REMIT: REconstruction of disease evolution in Mesothelioma for Improved Therapy (Cancer Research UK, 2023-2028) Using complex state of the art mouse models of cancer to improve the understanding and treatment of human cancer (Medical Research Council, 2022-2027) PREDICT-Meso: PRE-malignant Drivers Combined with Target-Drug validation in Mesothelioma (Cancer Research UK, 2020-2025) Professor Murphy leads a research group focused on oncogene-induced vulnerabilities, particularly studying how MYC and related pathways drive cancer development. His laboratory utilizes advanced genetically engineered mouse models to investigate lung cancer and mesothelioma pathogenesis, with recent work increasingly incorporating computational approaches to analyze complex histopathological data. The research has significant translational potential, with several recent studies identifying novel therapeutic targets across multiple cancer types.

Cecilie Thøgersen-Ntoumaniمشاهده پروفایل

استاد

• Health Behavior Change
• Motivational Science
• Physical Activity Promotion
• +۳ مورد دیگر

Professor Cecilie Thøgersen-Ntoumani holds a 125th Anniversary Chair as Professor of Health Behaviour Change at the University of Birmingham (on a fractional appointment since December 2024) and concurrently serves as Professor of Physical Activity and Health Behaviour at the University of Southern Denmark (SDU), where she co-directs the Danish Centre for Motivation and Behaviour Science (DRIVEN). She earned her PhD in Exercise and Health Sciences from the University of Bristol in 2003 and has held academic positions at the University of Birmingham, Curtin University (Australia), and SDU. Her research focuses on motivational science applied to health behavior change, emphasizing interventions for physical activity, body image, and climate adaptation. She is a top 2% global researcher (Ioannidis, 2023), an editorial board member for journals like Psychology of Sport and Exercise , and advises the Danish Heart Foundation on nationwide walking campaigns. Education: PhD in Exercise and Health Sciences, University of Bristol (2003) Research Interests: Motivational interventions for physical activity and weight management Vigorous Intermittent Lifestyle Physical Activity (VILPA) Peer-led initiatives and community engagement Body image and health behavior interactions Professional Roles: Editorial Board Member: Psychology of Sport and Exercise , Sport, Exercise and Performance Psychology Advisory Board Member: Danish Heart Foundation Co-Director: Danish Centre for Motivation and Behaviour Science (DRIVEN) Grants & Funding: Secured large interdisciplinary research funding, details of which are not specified in the text. Labs/Teams: Leads research at DRIVEN, focusing on motivation and behavior science applications.

Per-Henrik Groopمشاهده پروفایل

استاد

• Diabetes Research
• Endocrinology
• Nephrology
• +۵ مورد دیگر

Per-Henrik Groop serves as Research Director at the Department of Medicine Research Programs Unit, University of Helsinki, holding the title of Docent at Clinicum. He is actively involved as Supervisor for multiple doctoral programs including the Doctoral Programme in Biomedicine, Doctoral Programme in Clinical Research, and Doctoral Programme in Population Health. Affiliated with the HUS Abdominal Center, Dr. Groop has established himself as a leading international researcher in diabetes and its complications with an impressive publication record of 529 research outputs. Dr. Groop's research program focuses on understanding why only a subset of patients with diabetes develop serious complications, with particular emphasis on diabetic nephropathy, cardiovascular complications in type 1 diabetes, and the genetic determinants of these conditions. His work bridges clinical medicine with advanced genetic and molecular research approaches, often utilizing large cohort studies to identify risk factors and potential therapeutic targets. A significant portion of his research examines the interplay between genetic susceptibility and environmental factors in the development of diabetic complications. Analysis of Dr. Groop's recent publication trend reveals a continued strong focus on the mechanisms behind diabetic kidney disease and cardiovascular complications. His work spans from basic science investigations using animal models to large-scale clinical studies examining multiple organ systems affected by diabetes. A notable emphasis in his recent work is the examination of cumulative exposures to hyperglycemia and dyslipidemia and their long-term effects on organ damage in type 1 diabetes patients, with implications for clinical management strategies. Cunningham Lecture in Integrative Physiology: Diabetic complications – are they acquired or inherited? (2008) EASD Castelli Pedroli Prize – 24th Camillo Golgi Lecture: Diabetic nephropathy – means, motive and opportunity (2009) Kimmelstiel-Wilson Lecture: Baker IDI & George Institute Symposium, Diabetic nephropathy – an acquired or inherited diabetic complication? (2010) Novo Nordisk Foundation Lecture Award: Why does a subset of patients with diabetes develop kidney disease? (2012) Emil R. Rosenqvist's Prize (2013) Dr. Groop has supervised numerous doctoral students across multiple programs at the University of Helsinki, with a focus on type 1 diabetes complications, genetic factors in diabetes, and obesity-related complications. His supervision includes serving as primary supervisor or co-supervisor for doctoral theses on topics such as cerebral small vessel disease in type 1 diabetes, genetic and metabolomic factors of diabetic kidney disease, and obesity complications in type 1 diabetes. He is actively involved in significant research projects including the IMI2 Beat DKD project, which focuses on advancing understanding and treatment of diabetic kidney disease. Dr. Groop leads research activities at the HUS Abdominal Center in Helsinki and maintains extensive collaborations with researchers across Finland and internationally. His research group focuses on understanding the mechanisms behind diabetic complications, particularly nephropathy and cardiovascular disease, with the ultimate goal of developing better prevention strategies and personalized treatment approaches for patients with diabetes.

Shakil Ahmed Polashمشاهده پروفایل

پژوهشگر ارشد

• Nanomedicine
• Biomedical Engineering
• Materials Science
• +۳ مورد دیگر

Shakil Ahmed Polash is a Postdoctoral Research Fellow at RMIT University's School of Science, specializing in nanotechnology, biomedicine, and materials science. His research focuses on developing advanced materials for biomedical applications, including non-viral gene delivery and antimicrobial treatments. He holds a PhD in Applied Biology and Biotechnology from RMIT, where he has fostered global collaborations in Australia, Europe, and Asia. Polash's work bridges nanotechnology and healthcare, with recent projects involving smart nanomaterials for Group B Streptococcus sensing and point-of-care diagnostics. He has published over 30 peer-reviewed articles in high-impact journals and received awards such as the 2023 RMIT Best Scientific Image and 2021 Beautiful Science Competition recognition. His teaching contributions span biosciences, nanotechnology, and applied chemistry, with a focus on connecting theory to real-world applications. He actively supervises Honours and Master’s students, emphasizing hands-on learning and translational research. Polash also holds non-academic roles at RMIT’s Sir Ian Potter NanoBioSensing Facility and the Centre for Advanced Materials and Industrial Chemistry. Key research areas include nanomedicine, hybrid materials, and targeted drug delivery systems. His grants include the EMBL Australia Symposium Travel Grant (2022) and the Australian Synchrotron Beamline Grant (2021). Polash’s lab collaborations and industry partnerships aim to translate innovations into clinical solutions for infectious diseases.

• Aquaculture Nutrition
• Sustainable Feed Development
• Biorefinery Technology
• +۱۲ مورد دیگر

Margareth Øverland is a Professor at the Norwegian University of Life Sciences (NMBU), affiliated with the Faculty of Biosciences and the Department of Animal and Aquacultural Sciences. She serves as the Center Director of the Center for Research-based Innovation (CRI) Foods of Norway , a leading initiative in sustainable aquafeed development. Her work integrates advanced biotechnology and biorefinery approaches to create novel, renewable feed ingredients for aquaculture and livestock. Her research focuses on utilizing alternative resources such as tree biomass, marine macroalgae, insect meals, and microbial proteins (e.g., Paecilomyces variotii , yeast) to replace traditional feed components. She investigates their effects on animal growth, gut health, immune function, and product quality, with a strong emphasis on sustainability and circular economy principles. Her recent publications (2022–2025) reveal a clear trend toward high-impact, interdisciplinary studies involving meta-analyses, controlled field trials, and multi-omics approaches (proteomics, microbiome analysis). These works span aquaculture (Atlantic salmon, rainbow trout) and terrestrial livestock (pigs, poultry, dairy cows), demonstrating the broad applicability of her research. Keywords across her articles include sustainable feed, alternative proteins, immunonutrition, gut microbiota, and biorefinery technology. While no specific scientific awards are listed in the provided text, her leadership of a major CRI indicates national and likely international recognition. She is actively involved in advising through her research center and supervising projects, though individual student names are not provided. Her laboratory and team operate under the Foods of Norway CRI, which brings together interdisciplinary researchers to develop innovative feed solutions. The center likely includes expertise in bioprocessing, nutrition trials, microbiology, and environmental assessment, supporting large-scale, real-world applications of sustainable feed technologies.

Jaya Seneviratneمشاهده پروفایل

دانشیار

• Oral Microbiome
• Oral Biofilms
• Oral-Systemic Link
• +۳ مورد دیگر

Associate Professor Jaya Seneviratne is an academic and researcher in Periodontology at the University of Queensland's School of Dentistry, Australia. He serves as Director of Higher Degree Research (HDR) and is affiliated with the Centre for Orofacial Regeneration, Reconstruction and Rehabilitation (COR3). His expertise lies in oral microbiome dynamics, microbial biofilms, and oral-systemic health linkages. He holds a PhD from The University of Hong Kong (2008) and has secured over US$7.11 million in competitive grants. He has published over 100 papers in top dental journals and authored the book Microbial Biofilms: OMICS Biology, Antimicrobials and Clinical Implications (CRC Press, 2017). His research focuses on biofilm pathogenesis, antifungal drug discovery, and infection control strategies. Notably, his work bridges microbiology with clinical applications, including dental instrument disinfection and salivary biomarker discovery for diseases like diabetes. He has mentored numerous students who have won IADR awards, and his editorial roles include Journal of Dental Research and Critical Reviews in Microbiology . Key Achievements: IADR Asia Pacific Secretary (2019–2022), Session Committee Chair for IADR 2023 Current Projects: Developing novel holobiont modulation strategies for oral diseases and antimicrobial nanocomposites

• Exercise Physiology
• Sports Recovery
• Bone Health in Athletes
• +۸ مورد دیگر

Dr. Lygeri Dimitriou is a Senior Lecturer in the Department of Natural Sciences at Middlesex University, within the College of Science and Engineering. Her academic work is deeply rooted in applied sports science, focusing on the physiological and nutritional aspects of athletic performance and recovery. Her research interests span a wide range of topics in exercise physiology and sports medicine, including sports recovery strategies , bone health in dancers and endurance athletes , the female athlete triad , immune function in response to exercise and altitude , and performance optimization in elite sports such as fencing and cycling. She has extensively studied the effects of interventions like cold water immersion, whole body cryotherapy, and tart cherry juice on inflammation, oxidative stress, and recovery markers. The recent publication trends highlight a strong emphasis on randomized controlled trials and physiological monitoring in real-world athletic settings, from marathons to professional cycling and elite fencing. Her work frequently explores gender-specific responses, particularly in female athletes, and integrates both laboratory and field-based methodologies. Dr. Dimitriou has collaborated with numerous researchers across institutions and disciplines, contributing to a robust body of work published in reputable journals such as Frontiers in Sports and Active Living , Journal of Strength and Conditioning Research , and Scandinavian Journal of Medicine & Science in Sports . Her research has practical implications for strength and conditioning programs, injury prevention, and athlete health management. She completed her PhD at Brunel University in 2007, with a thesis on the effects of physical training on immune and health markers. Since then, she has maintained a consistent publication record and active research profile. While no formal advising roles or grants are explicitly mentioned, her collaborative nature and leadership in multiple studies suggest involvement in mentoring and research supervision. She is also associated with teams investigating high-altitude physiology (e.g., Team Everest) and dance science, indicating interdisciplinary engagement.

Rune Busk Damgaardمشاهده پروفایل

دانشیار

• Cellular Signaling
• Signal Transduction
• Ubiquitin Signaling
• +۸ مورد دیگر

Associate Professor Rune Busk Damgaard (PhD, University of Copenhagen) is affiliated with the Department of Biotechnology and Biomedicine at the Technical University of Denmark (DTU) , leading the Ubiquitin Signalling and Inflammation research group. His work bridges ubiquitin biology , cell signaling , and inflammatory disease , with a focus on innate immunity , cancer , and metabolic regulation . PhD, Center for Protein Research, University of Copenhagen (2011–2013) MSc and BSc in Molecular Biomedicine, University of Copenhagen Research Interests Ubiquitin signaling in inflammation and innate immunity Post-translational modification of proteins AMPK regulation under metabolic stress Aggrephagy and protein homeostasis in neurodegeneration Role of ubiquitin in inflammatory diseases and cancer Publication Trends (15 most recent): His articles explore ubiquitin linkage specificity , linear ubiquitin in immune signaling , AMPK metabolic pathways , and protein aggregate degradation . Collaborations span Cambridge , Oxford , and DTU , with applications in neurodegenerative diseases , cancer , and inflammatory disorders . Advising & Collaborative Networks Main supervisor for 5 PhD projects on ubiquitin signaling and metabolic regulation Peer reviewer for Cell Death and Differentiation , Biochemical Journal , and EMBO Journal Collaborations with institutions in UK , Germany , and Denmark

Lucas Changمشاهده پروفایل

استادیار

• Immunometabolism
• T Cell Biology
• Cancer Immunology
• +۷ مورد دیگر

Lucas Chang is an Assistant Professor affiliated with the Jackson Laboratory (JAX) and the Graduate School of Biomedical Science and Engineering (GSBSE) at the University of Maine. His research is centered on immunometabolism, with a focus on understanding how metabolic pathways regulate immune cell behavior in disease contexts such as cancer and autoimmunity. He leads a laboratory investigating T cell reprogramming within the tumor microenvironment, bridging immunology, metabolism, oncology, and bioinformatics. Dr. Chang earned his D.Phil. (Ph.D.) from the University of Oxford in 2010. His work has consistently explored the metabolic regulation of immune cells, particularly T cells, and its implications for therapeutic interventions. His research interests lie at the intersection of immunology and metabolism, with specific emphasis on T cell metabolic reprogramming , immune cell fate , and metabolic competition in the tumor microenvironment . His lab investigates how cellular and molecular metabolic events control immune responses during disease progression, aiming to develop novel strategies for immunotherapy, drug development, and disease prognosis. His work has significant implications for cancer treatment and autoimmune disorders like lupus. His recent publications (2023–2025) demonstrate a sustained and impactful research trajectory, with primary research articles and reviews appearing in top-tier journals such as Cell , Immunity , and Nature Immunology . The articles reveal a consistent theme of dissecting the metabolic dependencies of immune cells—T cells, B cells, and dendritic cells—under stress conditions like glucose restriction or chronic activation, and how these pathways can be therapeutically targeted in cancer and autoimmune diseases. Dr. Chang has not been mentioned to have received specific scientific awards in the provided text. He is actively involved in research and mentorship, as evidenced by his primary authorship on recent publications and his role as a principal investigator. His lab develops and publishes detailed protocols, indicating a commitment to methodological rigor and scientific sharing. He collaborates with a broad network of researchers across institutions. His laboratory, referred to as the 'Chang Bio' lab, is actively engaged in research on immune cell metabolism, utilizing advanced techniques like the Seahorse Extracellular Flux Analyzer for bioenergetic profiling and transcriptomic analysis to understand metabolic pathways in health and disease.

Michael Dahabiehمشاهده پروفایل

پژوهشگر ارشد

• Cancer Biology
• Metabolic Research
• Molecular Biology
• +۳ مورد دیگر

Dr. Michael Dahabieh is a Postdoctoral Fellow in the Russell Jones Laboratory , where he continues exploring intersections between cancer biology and metabolic research. He earned his Ph.D. in experimental medicine from McGill University and holds M.Sc. and B.Sc. degrees in molecular biology and biochemistry from Simon Fraser University . Education Ph.D., McGill University (experimental medicine) M.Sc., Simon Fraser University (molecular biology and biochemistry) B.Sc., Simon Fraser University (molecular biology and biochemistry) His research focuses on peroxisomes in tumor proliferation , CD8+ T cell metabolism , and nutrient-driven immune responses . His work employs techniques like immunoprecipitation , immunofluorescence , and flow cytometry to dissect metabolic pathways in cancer and immune cells. Recent publications highlight his contributions to understanding CD8+ T cell exhaustion , nutrient utilization , and metabolic reprogramming in tumor environments. His studies on glucose-dependent glycosphingolipid biosynthesis , histone acetylation , and MAPK-targeted therapies reveal novel mechanisms in immune and cancer metabolism.

Jean E. Schwarzbauerمشاهده پروفایل

استاد

• Extracellular Matrix Biology
• Cell-Matrix Interactions
• Fibronectin Assembly
• +۱۰ مورد دیگر

Jean E. Schwarzbauer is the Eugene Higgins Professor of Molecular Biology at Princeton University, where she leads a research group focused on the extracellular matrix (ECM) and its role in cell function and disease. She is affiliated with the Department of Molecular Biology, the New Jersey Center for Biomaterials, and the Rutgers Cancer Institute of New Jersey. Education: B.S. in Chemistry, University of Wisconsin–Milwaukee Ph.D. in Molecular Biology, University of Wisconsin–Madison Postdoctoral Fellowship, MIT Her research centers on fibronectin and ECM assembly, with implications in tissue development, regeneration, fibrosis, and cancer. She investigates how ECM structure regulates cell behavior, with a focus on fibronectin matrix formation, integrin signaling, and the role of proteoglycans. Her work spans basic molecular mechanisms to translational applications in regenerative medicine. Recent publications highlight her lab's work on fibronectin-binding protein signatures in pulmonary fibrosis, glucose-induced ECM changes in diabetic complications, and the use of engineered ECM-synthetic scaffolds for nerve regeneration. Her studies integrate cell biology, biochemistry, and biomaterials to uncover fundamental principles of matrix biology. Scientific Awards: Peggy Wheelock Award for Excellence in Research, Mentoring, and Promotion of Women in Science Professor Schwarzbauer has served as Director of Graduate Studies in Molecular Biology and Associate Chair of the department. She is actively engaged in service, having led the American Society for Matrix Biology, served on NIH study sections, and held editorial roles at Molecular Biology of the Cell , Matrix Biology , and Journal of Cell Biology . She has organized major scientific conferences and advised national research programs. Her lab trains students and postdocs in cutting-edge techniques in cell and matrix biology. Laboratory and Research Teams: The Schwarzbauer Lab at Princeton uses cell culture models, molecular biology, and imaging to study ECM dynamics. The team collaborates with bioengineers and clinicians to develop biomaterials for tissue repair. Ongoing projects include ECM in skeletal development, fibrosis mechanisms, and synthetic ECM design for regenerative applications.

Natalie Borgمشاهده پروفایل

دانشیار

• Innate immunity
• Microbial pathogenesis
• Antiviral drug discovery
• +۲ مورد دیگر

Associate Professor Natalie Borg is a faculty member in the Department of Health and Biomedical Sciences at RMIT University , Australia. She leads the Immunity and Immune Evasion Laboratory and holds the title of RMIT Senior Research Translation Fellow . Her research focuses on innate immunity and how pathogens manipulate immune responses. This work drives antimicrobial drug discovery programs and investigates nanostructured surface applications for viral inactivation. Scientific Awards NHMRC Peter Doherty Fellowship NHMRC Career Development Award L'Oreal for Women in Science Fellowship ARC Future Fellowship Her research programs have secured $3.65 million in competitive national funding from ARC, NHMRC, and the US Leukemia and Lymphoma Society, alongside $1.16 million in translational grants supporting multidisciplinary collaborations and a technology licensing agreement.

• Biomedical Research
• Physical Chemistry
• Analytical Chemistry
• +۷ مورد دیگر

Mayland Chang is a Research Professor in the Department of Chemistry and Biochemistry at the University of Notre Dame, within the College of Science. Her research spans biomedical chemistry, focusing on therapeutic interventions for chronic diseases and antibiotic-resistant infections. Research Interests: Understanding the molecular basis of diabetic wound healing through matrix metalloproteinase (MMP) activity, particularly MMP-8 and MMP-9. Designing novel small-molecule therapeutics such as ND-336 for diabetic foot ulcers. Developing new classes of antibiotics including quinazolinones and oxadiazoles to combat MRSA and Clostridioides difficile . Targeting bacterial resistance mechanisms, especially PBP2a in MRSA and spore germination pathways in C. difficile . The recent publications show a consistent trend in targeting pathogenic mechanisms at the molecular level, combining quantitative proteomics, enzyme kinetics, and in vivo evaluation. Her work bridges chemistry and translational medicine, aiming to deliver clinically relevant therapeutics. Scientific Leadership: Director, CBBI Program (2007–2022) Dr. Chang mentors graduate students and welcomes prospective applicants to join her lab. She has secured long-term research funding enabling sustained projects in antibiotic development and wound healing. Her collaborative work with Prof. Shahriar Mobashery highlights a strong interdisciplinary team approach. She is actively involved in cutting-edge research with ongoing projects identifying active MMPs in diabetic patients and optimizing oxadiazole compounds for C. difficile treatment.